#Monitor Diabetes From Your Smart Watch My son, Evan, was diagnosed with type 1 diabetes in August 2012.
Type 1 diabetes is an autoimmune disease that attacks the pancreas and prevents insulin production. The body needs insulin to transport glucose from the blood to the cells.
Synthetic insulin is used to manage type 1 diabetes, but it doesn work as quickly as human insulin.
Determining the right dose of insulin for a given meal carbohydrate content becomes an all-consuming balancing act.
as it allowed Evan some freedom from the typical type 1 diabetes regimen at day care.
because his life is disrupted far less by the demands of diabetes. We can mitigate most hyper
what we lost that day in August 2012 and blessed to know that my little boy diabetes has helped so many others.
This article originally appeared in print as IY Diabetes Remote Monitoring.
#Cheap Earthquake Warning Systems While predicting earthquakes remains a dream, scientists have developed early warning-systems systems that give people precious seconds to run out of buildings
#Diabetes Has a New Enemy: Robo-Pancreas The first great wonder drug was insulin, the blood-sugar-regulating hormone that was isolated in Canada nearly a century ago.
and closed-loop systems that take over more of the diabetes management are in trials. Finally, everybody in the field agrees that a solution is nigh.
People with diabetes often carry a special pen charged with glucagon for others to use on them
But at a diabetes technology conference held in Paris this past February, funding organizations appeared to have doubled down on the simpler one-hormone system in the hope that it will get approved more easily.
As the millions of people with type 1 diabetes work out the kinks in the new technology,
it will spread to the hundreds of millions with type 2 diabetes, many of whom would also benefit from insulin
They help people participate in tests for Parkinson, diabetes, cardiovascular disease, asthma, and breast cancer. Apple Jeff Williams came out on stage today at the Apple Watch event to show off Researchkit.
Google X is also creating contact lenses that can monitor blood glucose level to help in managing conditions like diabetes.
if I had a high risk or genetic predisposition toward heart disease, diabetes, or Alzheimer. I don,
but it can become essential for the millions living with chronic conditions like diabetes, heart disease, and depression.
#DNA-Based Research May have unveiled Long-Sought Diabetes Treatment A synthetic drug that controls blood sugar in obese mice demonstrates the potential of a DNA-dependent method for developing new chemical compounds.
By Susan Young Rojahn on May 23, 2014 WHY IT MATTERS The World health organization predicts that diabetes will be the seventh-leading cause of death by 2030.
and treat diabetes. Researchers have known long that the body carries an enzyme that breaks down insulin inside cells
and helps regulate the body response to sugars process that goes awry in type 2 diabetes.
Genetic studies have shown that people with type 2 diabetes are more likely to have mutations in the gene that encodes a protein called insulin-degrading enzyme, or IDE.
Patients with type 2 diabetes either have an insufficient amount of insulin in their blood
Researchers have speculated for decades that a drug that could inhibit IDE might help some type 2 diabetes patients.
The newly identified IDE inhibitor could be the starting point for developing a powerful new drug for type 2 diabetes.
#Researchers find new way to treat diabetic blindness WASHINGTON: US researchers said they have found a new way to restore the eyesight in patients who have a blinding eye disease caused by diabetes.
The key is to block a second blood vessel growth protein, along with one that is already well-known,
and preventing diabetic retinopathy, the most common diabetic eye disease, they reported in the US journal Proceedings of the National Academy of Sciences, Xinhua news agency reported.
Diabetic retinopathy occurs when the normal blood vessels in the eye are replaced over time with abnormal,
Forty to 45 percent of Americans with diabetes have diabetic retinopathy, according to the US National Eye Institute.
But studies have shown that although these drugs slow progression to proliferative diabetic retinopathy, it does not reliably prevent it,
people with diabetes who did not have diabetic retinopathy and people with diabetic retinopathy of varying severity were tested.
While levels of VEGF tended to be higher in those with proliferative diabetic retinopathy some of their fluid had less VEGF than did the healthy participants.
But even the low-VEGF fluid from patients with proliferative diabetic retinopathy stimulated blood vessel growth in lab-grown cells."
"The results suggested to us that although VEFG clearly plays an important role in blood vessel growth,
and angiopoietin-like 4 in fluid from the eyes of people with proliferative diabetic retinopathy, it markedly reduced blood vessel growth in lab-grown cells.
it might be combined with the anti-VEGF drugs to prevent many cases of proliferative diabetic retinopathy.
US researchers said they have found a new way to restore the eyesight in patients who have a blinding eye disease caused by diabetes.
and preventing diabetic retinopathy, the most common diabetic eye disease, they reported in the US journal Proceedings of the National Academy of Sciences, Xinhua news agency reported.
Diabetic retinopathy occurs when the normal blood vessels in the eye are replaced over time with abnormal,
Forty to 45 percent of Americans with diabetes have diabetic retinopathy, according to the US National Eye Institute.
But studies have shown that although these drugs slow progression to proliferative diabetic retinopathy, it does not reliably prevent it,
people with diabetes who did not have diabetic retinopathy and people with diabetic retinopathy of varying severity were tested.
While levels of VEGF tended to be higher in those with proliferative diabetic retinopathy some of their fluid had less VEGF than did the healthy participants.
But even the low-VEGF fluid from patients with proliferative diabetic retinopathy stimulated blood vessel growth in lab-grown cells."
"The results suggested to us that although VEFG clearly plays an important role in blood vessel growth,
and angiopoietin-like 4 in fluid from the eyes of people with proliferative diabetic retinopathy, it markedly reduced blood vessel growth in lab-grown cells.
it might be combined with the anti-VEGF drugs to prevent many cases of proliferative diabetic retinopathy.
The findings also provide strong evidence that certain type-2 diabetic drugs, belonging to a new class known as SGLT2 inhibitors
#New laser device spells end for diabetic finger pricking LONDON: A new technology developed by an Indian-origin scientist,
and eliminate the need for daily finger pricking for diabetics. Currently, many people with diabetes need to measure their blood glucose levels by pricking their fingers,
squeezing drops of blood onto test strips, and processing the results with portable glucometers. The new technology, developed by Professor Gin Jose and a team in the Faculty of engineering at the University of Leeds,
this technology opens up the potential for people with diabetes to receive continuous readings, meaning they are alerted instantly
and eliminate the need for daily finger pricking for diabetics. Currently, many people with diabetes need to measure their blood glucose levels by pricking their fingers,
squeezing drops of blood onto test strips, and processing the results with portable glucometers. The new technology, developed by Professor Gin Jose and a team in the Faculty of engineering at the University of Leeds,
this technology opens up the potential for people with diabetes to receive continuous readings, meaning they are alerted instantly
Previously, wee seen how medical researchers have been experimenting with something similar to create 3d bioprinted scaffolding for slowly introducing cells for a diabetic treatment process.
#Nanoparticles Arrest Destruction of Beta Cells and Avoid Diabetes Development This work led to more studies with the support of the Spanish Government, Catalan Government and private patrons with a keen interest in it.
and avoid Diabetes development. This technique could be a much better candidate for a human vaccine.
The Catalan researchers are the first group in the world to use liposomes that imitate naturally dying cells to fight against Diabetes.
Next stepsafter showing that liposomes prevent the onset of Type 1 Diabetes in mice, the next steps are to test it in human cells in vitro,
Growing incidence and complex consequencestype 1 Diabetes is an illness where the body does not recognize the beta cells of the pancreas as its own
what is called"Diabetics Foot"where ulcers form, leading eventually to the need to amputate. The causes of the disease are unknown,
This immunotherapy presents a possible solution for Type 1 Diabetes. Source: http://www. uab. es e
in order to avoid risks and painful treatments in people with secondary blindness due to chronic degenerative blindness such as diabetic retinopathy and degeneration of the eye.
"The doctor Juan carlos Altamirano Vallejo, medical director of the Medical and Surgical Center for Retina, mentions that the conditions that originate in the retina are caused mostly by chronic degenerative diseases such as diabetes (diabetic retinopathy
for example, diabetes, cancer, multiple sclerosis, and osteoporosis. Now Microchips Biotech will begin co-developing microchips with Teva Pharmaceutical, the world largest producer of generic drugs,
For the future the researchers also envisage the use of Glucolight in other fields such as diabetes s
--whose deregulation is associated with diseases ranging from diabetes to cancer to epilepsy--have gradually been brought to light.
and diabetes and we had figured out the core machinery of the pathway says Sabatini. But the mystery has been
or metabolic abnormalities associated with diabetes. Intriguingly because SLC38A9 activates the pathway it may represent a target for clinical situations in
#New Smart Insulin Patch May Replace Injections for Diabetics By Beth Ellisonthe mart insulin patchis a thin square a couple of millimetres large.
The research team found that the new patch could reduce blood glucose levels in a mouse model of type 1 diabetes for as long as nine hours.
"The whole system can be personalized to account for a diabetic's weight and sensitivity to insulin,
diabetes is maintained currently with frequent finger prick tests and insulin shots to control blood glucose levels.
or even more disastrous consequences such as diabetic comas and death.""This research team have removed the risk of human error by emulating the natural insulin generators of the body beta cells.
The team tested the patch on a mouse model of type 1 diabetes and compared it to injecting insulin as standard.
Insulin for people with diabetes has been made in genetically modified bacteria for decades. But there are concerns these latest advances could allow a DIY drug lord to brew illegal narcotics in their home."
or exploring the mechanisms behind conditions such as diabetic neuropathy.''The problem is that unlike blood, a skin sample or even a tissue biopsy,
For example, someone with diabetes who has chronic kidney problems. If the person needed to be tested every few hours, before a meal, after a meal,
and creates an increased risk for cancer and diabetes. When a healthy person is infected by a virus,
#Smart Insulin Patch Could Replace Painful Injections for Diabetes Painful insulin injections could become a thing of the past for the millions of Americans who suffer from diabetes, thanks to a new invention from researchers at the University of North carolina
painless patch could lower blood glucose in a mouse model of type 1 diabetes for up to nine hours.
but the approach shows great promise. e have designed a patch for diabetes that works fast,
and the UNC Diabetes Care Center. he whole system can be personalized to account for a diabetic weight and sensitivity to insulin,
Diabetes affects more than 387 million people worldwide, and that number is expected to grow to 592 million by the year 2035.
Patients with type 1 and advanced type 2 diabetes try to keep their blood sugar levels under control with regular finger pricks and repeated insulin shots, a process that is painful and imprecise.
M d.,Ph d.,co-senior author of the PNAS paper and the director of the UNC Diabetes Care Center, said,
or even more disastrous consequences such as diabetic comas and death. Researchers have tried to remove the potential for human error by creating losed-loop systemsthat directly connect the devices that track blood sugar
they had to figure out a way to administer them to patients with diabetes. Rather than rely on the large needles
The researchers tested the ability of this approach to control blood sugar levels in a mouse model of type 1 diabetes.
when administered too frequently. he hard part of diabetes care is not the insulin shots, or the blood sugar checks,
the director of the North carolina Translational and Clinical Sciences (NC Tracs) Institute and past president of the American Diabetes Association. f we can get these patches to work in people,
The research was funded by a pilot grant from the NC Tracs Institute and a athway to Stop Diabetesresearch Award from the American Diabetes Association.
for example, diabetes, cancer, multiple sclerosis, and osteoporosis. Now Microchips Biotech will begin co-developing microchips with Teva Pharmaceutical, the world largest producer of generic drugs,
including diabetes, infections and cancers. The research team, led by Dr. James Anstie, Australian Research Council (ARC) Research Fellow with the University Institute for Photonics and Advanced Sensing (IPAS), compared the instrument to an ptical dog nosewhich uses a special laser to measure the molecular content
asthma and diabetes can be detected in this way, even before external symptoms are showing. owever, Anstie told Bioscience Technology, ther conditions,
#Ultrasound Accelerates Skin Healing Especially for Diabetics and the Elderly Researchers from the University of Sheffield Department of Biomedical science discovered the ultrasound transmits a vibration through the skin
when treating diabetics and the elderly. There are 11 million over-65s, three million diabetics and 10 million smokers in the UK all of whom are likely to suffer problems with healing wounds.
A quarter of diabetics suffer from skin ulcers, particularly foot ulcers, due to the loss of sensation and circulation in the legs.
Lead author of the study Dr Mark Bass, from the University Centre for Membrane Interactions and Dynamics (CMIAD), said:
Apple launched its Researchkit program in March with five apps to investigate Parkinson's, asthma, heart disease, diabetes and breast cancer.
Because these immune-system cells play important roles in a wide range of diseases, from diabetes to AIDS to cancer, the achievement provides a versatile new tool for research on T cell function,
Apple launched its Researchkit program in March with five apps to investigate Parkinson's, asthma, heart disease, diabetes and breast cancer.
#New martinsulin Patch Could Change Everything For Diabetics A new martinsulin patch could do away with painful injections
and revolutionize the way diabetics keep their blood sugar levels in check. For people affected by diabetes,
monitoring and regulating insulin levels can be a tedious and dangerous task. I remember my own grandmother,
a type II diabetic, would have a sugary snack on her at all times in case her blood sugar levels suddenly dropped,
showed promising results in a mouse model of type 1 diabetes. Researchers hope to see similar success in subsequent clinical trials in humans. he whole system can be personalized to account for a diabetic weight
and sensitivity to insulin, said co-senior author Zhen Gu in a statement, o we could make the smart patch even smarter.
researchers suggest the patch can have a longer-lasting effect in diabetic patients. The patch emulates beta cells
sending insulin into the bloodstream. he hard part of diabetes care is not the insulin shots,
like heart disease or diabetes. revention is the most viable approach to reduce the socioeconomic burden of chronic and widespread diseases,
While medical injections are unpleasant and inconvenient, theye also necessary for people with illnesses like diabetes.
#India diabetes rate has jumped 123 %since 1990 A global health survey showed that rates of diabetes among Indians has grown at an alarming rate since the early years of the country emergence as a world power.
Between 1990 and 2013, India saw instances of diabetes grow by 123, %with researchers attributing this to the way lifestyles have changed over that time.
The study looked at 301 acute and chronic diseases and injuries in 188 countries, finding that developing nations like India and China are now mimicking a trend that had began earlier in Western nations.
The biggest increase the researchers observed was in Type 2 diabetes the most common form of the disease which is linked most often to obesity.
Endocrinologist Anoop Misra told Times of India that diabetes was an escalating problem in India
and had major socioeconomic dimensions. apid dietary changes coupled with decreased level of physical activity have resulted in increasing obesity and diabetes in rural and semi-urban areas,
Diabetes did no feature in the top 10 of India diseases in 1990, whereas it is the country eighth-biggest killer.
a tool that could be used for biomolecular tests such as pregnancy or diabetes monitoring. Surface plasmon resonance (SPR) is a process where a stream of light is directed onto a metallic film, with most,
the elderly and those with diabetes. When a young and healthy person incurs an injury to the skin,
It found the technique reduced healing times by 30 percent in aged and diabetic mice,
#Laser device may soon non-invasively monitor diabetics'glucose levels In order to monitor their blood glucose levels, diabetics typically have to perform painful and inconvenient finger-prick blood tests in some cases, several times a day.
Using an implantable glucose-monitoring sensor is one alternative, although it must be installed surgically and subsequently removed for replacement.
this technology opens up the potential for people with diabetes to receive continuous readings, meaning they are alerted instantly
or readings directly to doctors, allowing them to profile how a person is managing their diabetes over time."
The team was developing implantable capsules that can hold pancreatic islet cells as a potential therapy for Type 1 diabetes.
What investigators discovered is that spherical capsules 1. 5 millimeter in diameter were functional months after implantation in diabetic mice,
Currently, finger pricking is the daily grind of diabetics worldwide, which also involves careful pipetting of the blood samples into the glucometer.
The growing prevalence of diabetes and obesity has increased the risk factors for bedsores.""The genius of this device is that it's looking at the electrical properties of the tissue to assess damage.
Nanotechnology shows promise for more accurate prostate cancer screening and prognosis March 17th, 2015'Additive manufacturing'could greatly improve diabetes management March 17th, 2015nanotechnology Drug Delivery Market in the US 2012-2016:
News and information'Additive manufacturing'could greatly improve diabetes management March 17th, 2015harris & Harris Group Reports Financial statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th, 2015four
2015nanomedicine'Additive manufacturing'could greatly improve diabetes management March 17th, 2015nanotechnology Drug Delivery Market in the US 2012-2016:
2015announcements'Additive manufacturing'could greatly improve diabetes management March 17th, 2015harris & Harris Group Reports Financial statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th,
News and information A step towards a type 1 diabetes vaccine by using nanotherapy June 10th, 2015investigation of Optical Properties of Quantum dots in Presence of Magnetic, Electrical Fields June 10th,
2015discoveries A step towards a type 1 diabetes vaccine by using nanotherapy June 10th, 2015investigation of Optical Properties of Quantum dots in Presence of Magnetic, Electrical Fields June 10th,
2015announcements A step towards a type 1 diabetes vaccine by using nanotherapy June 10th, 2015investigation of Optical Properties of Quantum dots in Presence of Magnetic, Electrical Fields June 10th,
2015interviews/Book reviews/Essays/Reports/Podcasts/Journals/White papers A step towards a type 1 diabetes vaccine by using nanotherapy June 10th,
and innovation programm 1 e. Its main objective is to reach a level of international excellence in nanomedicine characterisation for medical indications like cancer, diabetes, inflammatory diseases or infections,
The bacteria thus programmed detect the abnormal presence of glucose in the urine of diabetic patients.
and detected the abnormal presence of glucose in the urine of diabetic patients.""We have deposited the genetic components used in this work in the public domain to allow their unrestricted reuse by other public
#Smart insulin patch could replace injections for diabetes Painful insulin injections could become a thing of the past for the millions of Americans who suffer from diabetes, thanks to a new invention from researchers at North carolina State university and the University
painless patch could lower blood glucose in a mouse model of type 1 diabetes for up to nine hours.
A paper describing the work is published in the Proceedings of the National Academy of Sciences. e have designed a patch for diabetes that works fast,
and the UNC Diabetes Care Center. he whole system can be personalized to account for a diabetic weight and sensitivity to insulin,
Diabetes affects more than 387 million people worldwide, and that number is expected to grow to 592 million by the year 2035.
Patients with type 1 and advanced type 2 diabetes try to keep their blood sugar levels under control with regular finger pricks and repeated insulin shots, a process that is painful and imprecise.
MD, Phd, co-senior author of the PNAS paper and the director of the UNC Diabetes Care Center, said,
or even more disastrous consequences such as diabetic comas and death. Researchers have tried to remove the potential for human error by creating losed-loop systemsthat directly connect the devices that track blood sugar
they had to figure out a way to administer them to patients with diabetes. Rather than rely on the large needles
The researchers tested the ability of this approach to control blood sugar levels in a mouse model of type 1 diabetes.
when administered too frequently. he hard part of diabetes care is not the insulin shots, or the blood sugar checks,
the director of the North carolina Translational and Clinical Sciences (NC Tracs) Institute and past president of the American Diabetes Association. f we can get these patches to work in people,
for example, diabetes, cancer, multiple sclerosis, and osteoporosis. Michael Cima (left) and Robert Langer Now Microchips Biotech will begin co-developing microchips with Teva Pharmaceutical, the worlds largest producer of generic drugs,
Furthermore, white blood cell count can be used to predict a person risk of developing conditions such as diabetes and heart disease.
and Surgical Center for Retina developed software that detects eye diseases such as diabetic macular edema using a smartphone.
like heart disease or diabetes. Need for prevention revention is the most viable approach to reduce the socioeconomic burden of chronic and widespread diseases,
allowing clinicians to better observe changes after treatment or perhaps enabling new ways to monitor diabetes."
a mobile retinal imaging system intended to bring routine diagnostic retinal examinations-in particular for diabetic retinopathy-to developing countries where standards of eye care are low,
-prick blood tests unnecessary for people with diabetes. Glucosense Diagnostics Ltd. intends to make tabletop and wearable versions of the device,
this technology opens up the potential for people with diabetes to receive continuous readings, meaning they are alerted instantly
or readings directly to doctors, allowing them to profile how a person is managing their diabetes over time."
"Noninvasive monitoring will be particularly valuable in young people with Type 1 diabetes, "Grant said.""Within this group, those who are attempting very tight control,
than develop diabetes or heart disease. Kidney stones cause severe pain, obstruction of the urinary tract, and loss of worker productivity.
and Surgical Center for Retina have developed software that detects eye diseases such as diabetic macular edema using a smartphone.
"Conduct routine eye examinations and retinal screenings anywhere for possible detection of a variety of disorders, including the leading causes of blindness-cataracts, glaucoma, diabetic retinopathy and age-related macular degeneration,
#This new insulin patch could soon replace injections for diabetics A new'smart patch'lined with painless microneedles full of insulin has been developed by researchers in the US in an effort to do away with the uncomfortable injections that have become a part of life for the millions
of type 1 diabetics around the world who need to manually regulate their hormone levels.
"We have designed a patch for diabetes that works fast, is easy to use, and is made from nontoxic,
"The whole system can be personalised to account for a diabetic's weight and sensitivity to insulin,
it was able to regulate the insulin levels of diabetic mice for nine hours straight.
And obviously mice are useless at monitoring their blood-sugar levels the way human diabetics have to right now,
or even more disastrous consequences such as diabetic comas and death.""The system inside the patch was built to mimic the body own insulin generators, known as beta cells.
Genius."The hard part of diabetes care is not the insulin shots, or the blood sugar checks,
The sensor, reported in a proof-of-concept study in the ACS journal Analytical Chemistry, has the potential to eliminate finger-pricking for many people with diabetes.
Joseph Wang and colleagues in San diego note that diabetes affects hundreds of millions of people worldwide.
The researchers conclude that the device could potentially be used for diabetes management and for other conditions such as kidney disease e
#More clues to how drug reverses obesity diabetes fatty liver disease In addition to illuminating how the drug amlexanox reverses obesity diabetes
and fatty liver disease the findings suggest a new pathway for future treatments. The research was published Jan 12 in Nature Communications.
and improve diabetes in obese mice. The current study revealed that amlexanox exerts its effects through a specialized type of fat cell by increasing the level of a second messenger molecule called camp.
In the livers of diabetic mice interleukin-6 reduces production of glucose so that overall blood sugar is lowered.
The finding is the latest piece of a complex obesity-inflammation-diabetes puzzle that Saltiel lab investigators have been working to solve
In 2013 the researchers discovered that amlexanox an off-patent drug currently prescribed for the treatment of asthma and other uses reversed obesity diabetes and fatty liver in mice.
The U-M study explains how increased camp in fat cells promotes the secretion of the hormone interleukin-6 which signals the liver to stop producing glucose--thus improving overall blood sugar levels in obese diabetic mice e
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011